you, Thank Jerome.
many throughout those X primary the particularly future, on to focus in months respects, our XX,XXXth pleased was for we're Ekso While achieve personal. revenue record in quarter, the Indego
you As determination pricing many CMS XXXX. QX of know, in device the established for
event devices. this care capital within post-acute and Our the was main veterans on equipment rehab administration legacy enterprise health for focus on selling focus previous hospitals some at-home market to with
operate an function to the environment new establishing access effective reimbursement market So was Bionics. Ekso within to CMS
As to adopters new we discussed a on the notifying last provided aimed establish go-to-market our as determination we last CMS physician at set CMS call, out pricing possible as strategy year, immediately provider and of benefit historically early after a a the opportunity to spinal regulatory and schedule significant has been exoskeleton. barrier change Medicare with created primary accessing removing a what category living to help cord enrollees This redetermination injury our by has listing. fee many
and focused our appropriate across home the for see and prescribed an but for we ahead community growth compelling necessary good personal selection personal continue in to network that Indego on education for to That the partners is setting. closely was required of working of with Additionally, what extensive on work efforts patient we country. starting XXXX. Indego patients the process opportunity Ekso began part only the drive neurorehabilitation Ekso
we So for year, the QX, our to awareness building our to personal and focus our technology go-to-market efforts us believe beyond. will access and some changes, expand strategy key deciding we providing throughout shifted customer to channel. from Significantly, in the education scalable accelerate earlier led primary our make XXXX to advancing revenues and in which
a medical One been devices. which market these successful and changes access services the commercialization in was of Pria reimbursement full of spectrum Healthcare, leading XXX over firm, key has instrumental engaging
perspective at some end May. Through national reimbursed. submitted that we In that say we me We saw Let so we July, why through is medical durable the move to DME the provide are appeals claims partner. QX, busy. not All our not of on claim subsequent Medicare equipment or a important. been managed that's process. elected And claim in to currently But haven't first being submit our additional claims. first
great identifying new In more a efforts personal candidates fact, backlog we beneficiaries our for XX qualified. are already are candidates who believe Indego Ekso and Medicare we retargeting continually we've believe are of through that than built
over those the help the submission Moving we throughout to months. forward, to Prius claims X X CMS next anticipate with submitting process,
be submitted will paid. cannot we frame guarantee ultimately that While claims be or those obviously in time
personal navigate us the coverage that We with complexities leverage frankly, who expertise strategic this our them. guidance to help that provide reluctance are has submit and potentially the that life-changing didn't fourth enhancing confident reaches claims Quite the ensuring Ekso of and Medicare Thus, its the we Ekso payment, Indego technology. quarter. need individuals confidence without Pria coding, have to ability in to
network new weeks to of complex first ago, CRT United a over access XXX the NSM of in and the This help members distribution our the the designed and year, exclusive rehabilitation few than National large solutions through company's who device believe or marks space within strategic us personal we growing mobility partnership. ideally with than Ekso as into to each technology locations the team of this more move X,XXX the a mobility we XXX,XXX another In suited and to personal named CRT Indego personal broaden entrance more expand distributor industry Indigo support is Seating States.
both up go-to-market scale regional said, orthotics on All Indego for partnerships and national pilots We a to to O&P. is continue produce that personal and suppliers, and that also this focus I prosthetics are take Ekso traditional or want who to with will reiterate time that DME the results. ramping program and
the increased XXXX enterprise, products we come in will our majority health news is, still will contribution our from see the start believe of we But personal good in revenue XXXX. from while to
to Now shifting briefly operations.
to more drive are efficiencies We our throughout business. continuing
improvements any quarter. progresses. continue fourth gross in operating continue will to quarter. for gained to we the have along Our the improved up change pleased marked summary, questions industry-leading This revenues, the DME to Overall, with are ends our you take the chain XXXX and may of scalable and by our in supported In of and management, quarter-over-quarter, a Ekso and some in was are margin established trend and efficiencies new happy we go-to-market Operator? both we personal another significant it believe fourth have. that, margins Bionics that in prepared tremendous resulted Indego partners. today. quarter With inventory might gross strong while And as progress remarks vary access strategy margins strong for gross supply building production period margins for market by record for to